News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nurix completed HSR clearance for its Roche collaboration on BTK degrader bexobrutideg, receiving $700M upfront and up to $2.3B in milestones.
  • Range Resources reported strong Q2: $235M operating cash flow, record drilling efficiencies, and significant share repurchases with $1.4B buyback capacity.
  • FDA granted EUA for OraSure's OraQuick Ebola 2.0 rapid antigen test and OraSure is increasing production to meet outbreak demand.
  • Weatherford's Q2 revenue fell 4% and net income dropped 64%, citing Middle East tensions while acquiring NCS Multistage and planning redomestication.
  • Celldex's Phase 2 barzolvolimab trial in prurigo nodularis failed primary endpoints, leading the company to discontinue the PN program.
  • CN Healthy Food Tech received a Nasdaq delisting determination over disclosure issues and will seek a hearing, creating listing uncertainty.

Latest Articles

Abundia Global Impact Group Expands Leadership Team with the Appointment of Keith Berger as Chief Commercial Officer

Abundia Global Impact Group Expands Leadership Team with the Appointment of Keith Berger as Chief Commercial Officer

Abundia Global Impact Group, a low-carbon energy company specializing in converting waste into fuels, has appointed Keith Berger as Chief Commercial Officer. With over 25 years of experience in energy and technology sectors, Berger will lead the company's commercialization strategy, focusing on scaling its waste-to-fuels and renewable chemicals bus…

OSS Receives Production Order from Commercial Robotics Customer

OSS Receives Production Order from Commercial Robotics Customer

One Stop Systems, a Nasdaq-listed company specializing in rugged AI and edge computing solutions, announced it has received an initial $2.2 million production order from a manufacturer of autonomous construction and mining equipment following successful prototype testing. Deliveries will span from Q3 2026 through Q3 2027, with anticipated cumulativ…

Exyn Defense Advances U.S. Government Strategy with Green UAS Certification Initiative for Nexys Autonomous Mapping Platform

Exyn Defense Advances U.S. Government Strategy with Green UAS Certification Initiative for Nexys Autonomous Mapping Platform

Exyn Defense, the defense division of Exyn Technologies, announced the start of the Green UAS certification process for its Nexys modular autonomous mapping platform. This certification aligns Nexys with key U.S. government procurement standards, positioning the platform for broader adoption across Department of Defense, federal agencies, and publi…

Westlake Announces Second Quarter 2026 Conference Call

Westlake Announces Second Quarter 2026 Conference Call

Westlake Corporation, a global manufacturer of materials and innovative products, will release its second quarter 2026 earnings before market open on August 4, 2026, followed by a conference call to discuss the results. The company provides vital materials across housing, construction, packaging, healthcare, automotive, and consumer goods sectors.

Kratos Receives Mobile Counter-Unmanned Aircraft System(C-UAS) Approximate $156 Million Single Award Contract by U.S. Department of Energy Office of Secure Transportation

Kratos Receives Mobile Counter-Unmanned Aircraft System(C-UAS) Approximate $156 Million Single Award Contract by U.S. Department of Energy Office of Secure Transportation

Kratos Defense & Security Solutions has secured an approximate $156 million single-award contract from the U.S. Department of Energy's National Nuclear Security Administration Office of Secure Transportation. The contract supports Project Solar Shield, under which Kratos will deliver mobile Counter-Unmanned Aircraft System (C-UAS) platforms aimed a…

CISO Global Advances AI Software-Led Cybersecurity Strategy with FedRAMP-Certified TiGRIS GRC Platform

CISO Global Advances AI Software-Led Cybersecurity Strategy with FedRAMP-Certified TiGRIS GRC Platform

CISO Global, Inc. announced the expansion and automation of its TiGRIS governance, risk, and compliance (GRC) platform, which is FedRAMP-certified and designed for complex regulatory environments. The company plans to integrate generative AI capabilities to improve compliance intelligence and risk visibility. This development marks a key step in CI…

Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care

Smith+Nephew introduces expanded enterprise ASC Solutions Strategy to support growth, performance and value-based care

Smith+Nephew has introduced ASC Solutions, an expanded enterprise strategy focused on ambulatory surgery centers (ASCs) to support cost optimization, quality, and outcome performance. The initiative includes the ASC ONE delivery model, integrating a network of partners to streamline ASC development and operations, providing a unified customer exper…

VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

VYNE Therapeutics announced a 1-for-50 reverse stock split in connection with its proposed merger with Yarrow Bioscience, expected to close around July 24, 2026. Post-merger, the combined company will trade under the ticker YARW on Nasdaq. VYNE also provided an update on a special cash dividend of $17.3 million payable to stockholders before the re…

Enphase Energy Unlocks Backup and Expandable Storage for Existing IQ Battery Customers Across Europe

Enphase Energy Unlocks Backup and Expandable Storage for Existing IQ Battery Customers Across Europe

Enphase Energy announced a new upgrade for European homeowners with existing second-generation IQ Battery systems, allowing them to add backup power and expand their storage capacity using new Enphase products without replacing current batteries. This upgrade enhances energy independence, supports increasing household electricity demands such as EV…

Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

Rhythm Pharmaceuticals to Report Second Quarter 2026 Financial Results on Tuesday, August 4, 2026

Rhythm Pharmaceuticals, a commercial-stage biopharmaceutical company specializing in treatments for rare neuroendocrine diseases, announced it will report its Q2 2026 financial results and host a conference call on August 4, 2026. The company’s lead drug, IMCIVREE (setmelanotide), is FDA-approved for treatment of obesity related to specific genetic…

Business Insider Launches Standalone FAST Channel, Partners with Magnite’s SpringServe for Next Phase of Streaming Growth

Business Insider Launches Standalone FAST Channel, Partners with Magnite’s SpringServe for Next Phase of Streaming Growth

Magnite announced that Business Insider has selected its SpringServe video platform to power ad serving and programmatic monetization of its new standalone FAST connected TV (CTV) channel. This move extends Business Insider’s premium video content to third-party platforms, aiming to deepen audience and advertiser engagement within the streaming eco…

ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology

ASP Isotopes Announces Quantum Leap Energy Research Agreement with Texas A&M Engineering Experiment Station to Advance Uranium Conversion Technology

ASP Isotopes Inc.'s subsidiary Quantum Leap Energy has entered a research agreement with Texas A&M Engineering Experiment Station to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6), critical to the nuclear fuel enrichment process. This collaboration aims to improve production efficiency, reduce costs, and sup…

Rezolve Ai Brings Agentic Commerce Infrastructure to Zilch’s Payments Platform Serving Nearly 6 Million Customers

Rezolve Ai Brings Agentic Commerce Infrastructure to Zilch’s Payments Platform Serving Nearly 6 Million Customers

Rezolve Ai announced a strategic partnership with Zilch, a UK fintech unicorn, to embed Rezolve Ai's agentic commerce infrastructure into Zilch's payment platform via the Reward platform. This integration aims to provide personalized retailer engagement for nearly 6 million customers, enhance consumer value from everyday spending, and drive signifi…

Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel

Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel

Verrica Pharmaceuticals Inc., a US-based dermatological therapeutics company, announced an exclusive distribution, marketing, and supply agreement with Medomie Pharma Ltd. for the commercialization of YCANTH®, a prescription treatment for molluscum contagiosum, in Israel. Under the agreement, Medomie will seek regulatory approvals and distribute th…

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Cadrenal Therapeutics has aligned its cardiac critical care portfolio into a focused franchise and initiated partnering discussions for its late-stage assets including CAD-1005, frunexian, and tecarfarin. Promising Phase 2 data for CAD-1005 indicated a significant reduction in thrombotic events, bolstering the company’s strategy to leverage partner…